Please note that attendance is strictly for current members of recognized Biotech, Pharma, and MedTech organizations ONLY. Every attendee is screened and approved upon application.
Hinxton, Saffron Walden CB10 1SA
5 Blvd. de La Tour-Maubourg
We bring the Life Science Leader Summit to leading academic settings, appropriate for our high level discussions.
Although we have multiple dates and locations, we have the same core schedule that stimulates conversation on the biggest headwinds facing the industry.
Chief Medical Officer
8 person roundtables
Only the Life Science Leader Summit offers a private forum of accomplished peers from Biotech, Pharma, and MedTech that gather to share and solve industry challenges
or you can sign in using email
This is the most important year for BioPharma and MedTech. Your voice is needed.
From entrepreneurs to developers, marketing managers, CEOs and policymakers – all of our 5,000 attendees are looking to stay on top of the latest trends
All current employees of bonefide biotech, pharma, or medtech companies are welcome. Roles of past attendees include: sales, managed markets, training, operations, medical affairs, clinical affairs, compliance, executive leadership, and more.
No. We are thankful for the many industry partners that help our businesses; however, LS2 is designed for and run by life science executives.
Please see the Passes section of this page for more information on current pricing
In the last two years of the Summit series, all attendees have had their employer reimburse them for their pass. This is a common developmental expense. All top 100 biopharma companies have had employees at our Summits.
We do not provide details of other attendees to scholars. Please use the LinkedIn group (Life Science Leader Advisor Group) to enquire about others going as well as hear from past attendees.
Attendees have included employees from:
Amgen, Biogen, Genentech, Gilead Sciences, GRAIL, Aimmune, Sage Therapeutics, Alkermes, GSK, Merck, Sanofi, Novartis, Bristol Myers Squibb, Spark Therapeutics, UCB, Acadia Pharmaceuticals, Retrophin, Otsuka, AMAG, Takeda, Shire, Alnylam, Dicerna, Aegerion, Zealand Pharma, Agios, Dicephera, Concert Pharma, Ohana Bioscience, bluebird bio, Momenta, Lilly, Sarepta, Regeneron, Acorda, Vertex, Sunovion, Dermira, Corcept, Amarin, Alexion, Akcea, Adamas, Abbott, AbbVie, Blueprint Medicines, Voyager, DexCom, Evidation, Livongo, and many more.
ARSENAL ADVISORS is a peer driven community of accomplished life science executives that shape the future of commercialization. Together, we create content and experiences that access ideas and accelerate innovation.
Copyright 2020 – All Rights Reserved